Cargando…
Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
Objective: Differential diagnosis of neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) or mimics can be challenging, especially in patients with atypical presentations and negative serostatus for aquaporin-4 antibodies (AQP4-Ab). This brief research report describes magneti...
Autores principales: | Wagner, Franca, Grunder, Lorenz, Hakim, Arsany, Kamber, Nicole, Horn, Michael P., Muellner, Julia, Hoepner, Robert, Wiest, Roland, Metz, Imke, Chan, Andrew, Salmen, Anke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170610/ https://www.ncbi.nlm.nih.gov/pubmed/30319524 http://dx.doi.org/10.3389/fneur.2018.00782 |
Ejemplares similares
-
Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015) -
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
por: Scheibe, Franziska, et al.
Publicado: (2018) -
Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)
por: Rodney, Cady, et al.
Publicado: (2020) -
Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder
por: Lin, Wei, et al.
Publicado: (2023) -
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)